P&G stops sale of Vicks Action 500 Extra in India after ban | business | Hindustan Times
Today in New Delhi, India
Aug 19, 2017-Saturday
-°C
New Delhi
  • Humidity
    -
  • Wind
    -

P&G stops sale of Vicks Action 500 Extra in India after ban

US consumer health giant Procter & Gamble’s India unit said on Tuesday it had stopped manufacture and sale of its cough-and-cold medicine Vicks Action 500 Extra with immediate effect, after regulators banned it citing potential health risk.

business Updated: Mar 15, 2016 10:44 IST
US consumer health giant Procter & Gamble’s  India unit said on Tuesday it had stopped manufacture and sale of its cough-and-cold medicine Vicks Action 500 Extra with immediate effect, after regulators banned it citing potential health risk.
US consumer health giant Procter & Gamble’s India unit said on Tuesday it had stopped manufacture and sale of its cough-and-cold medicine Vicks Action 500 Extra with immediate effect, after regulators banned it citing potential health risk.(Reuters)

US consumer health giant Procter & Gamble’s India unit said on Tuesday it had stopped manufacture and sale of its cough-and-cold medicine Vicks Action 500 Extra with immediate effect, after regulators banned it citing potential health risk.

The product is a fixed dose combination of paracetamol, phenylephrine and caffeine, which was banned by India’s health ministry in a notice issued over the weekend, Procter & Gamble Hygiene and Health Care informed the stock exchange.

The drug was one of 344 drug combinations including several antibiotics and analgesics that India ordered to be prohibited saying a government-appointed panel of experts had found the combinations lacked “therapeutic justification.”

P&G said all its products, including Vicks Action 500 Extra, were backed by research to support their quality, safety and efficacy.

It wasn’t immediately clear how much the product contributed to P&G’s sales